Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00782886 · ClinicalTrials.gov registry record
Evaluation of Image-Guided Liver Surgical System for Resection of Liver Cancer
A clinical trial of Liver Cancer, sponsored by Pathfinder Therapeutics.
- Completed
- Registry status
- 75
- Enrollment target
- 3
- Study locations
NCT00782886: Completed study of Liver Cancer, sponsored by Pathfinder Therapeutics.
NCT00782886 is a study of Liver Cancer that has completed, run by Pathfinder Therapeutics. The registered enrollment target is 75 participants, below the 447-participant average among 78 other Liver Cancer trials with a reported enrollment target (83% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00782886, a study of Liver Cancer, has completed, sponsored by Pathfinder Therapeutics.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
- 3
- Study locations
Study Summary
Image-guided surgery essentially describes the interactive use of medical images during a surgical procedure and is often referred to as a "global positioning" system (GPS) for surgery.
Conditions Studied
Study Locations (3)
Florida
- University of Florida Department of Surgery - Gainesville
New York
- Memorial Sloan Kettering Cancer Center - New York
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2008-04 |
| Est. Completion | 2010-11 |
What the finished NCT00782886 record still lists
NCT00782886 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 447-participant average among 78 other Liver Cancer trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Liver Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00782886 reports a single indexed study location in Florida, New York, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00782886 about?
NCT00782886 is a clinical study titled "Evaluation of Image-Guided Liver Surgical System for Resection of Liver Cancer". Image-guided surgery essentially describes the interactive use of medical images during a surgical procedure and is often referred to as a "global positioning" system (GPS) for surgery.
What is the current status of trial NCT00782886?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2008-04. Estimated completion is 2010-11.
What conditions does trial NCT00782886 study?
This clinical trial studies the following conditions: Liver Cancer.
Who is sponsoring clinical trial NCT00782886?
This trial is sponsored by Pathfinder Therapeutics, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00782886 being conducted?
This trial has 3 study locations across Florida, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00782886's enrollment target sits among peer trials
75 34th of 78 higher than 45 of 78 other Liver Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Liver Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility Study of CBCT for IGRT in Cancer Patients
RECRUITING · NA
-
Collection of Blood From Patients With Cancer
RECRUITING
-
National Liver Cancer Screening Trial
RECRUITING · Phase 4
-
vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC
RECRUITING · NA
-
Multi-analyte Blood Test Clinical Trial
RECRUITING
-
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia